← Back to Clinical Trials
Recruiting NCT06362330

Multi-parametric MRI in Patients of Bladder Cancer

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Muscle-invasive Bladder Cancer
Sponsor The First Affiliated Hospital with Nanjing Medical University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 1,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2021-07-01
Completion 2024-05-30
Interventions
magnetic resonance imaging

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Accurate preoperative detection of muscle-invasive bladder cancer remains a clinical challenge. The investigators aimed to develop and validate a knowledge-guided causal diagnostic network for the detection of muscle-invasive bladder cancer with multiparametric magnetic resonance imaging(MRI).

Eligibility Criteria

Inclusion Criteria: * Urothelial carcinoma of the bladder confirmed by final histopathology ②Received a standard contrast-enhanced 3.0T mpMRI before surgery ③All tumors within patients included were resected and received pathologic examination separately Exclusion Criteria: ①Absence of surgical interventions ②With inadequate image quality or with inadequate pathology for analysis

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE MUSCLE-INVASIVE BLADDER CANCER TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}